Abiopharma

🔍 Li Dean Y (Director)

Company: RECURSION PHARMACEUTICALS, INC. (RXRX)

Report Date: 2026-06-17

Detailed Transactions and Holdings:

• Acquired 88,424 shares of Class A Common Stock (Direct)
  Date: 2026-06-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,469,582.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-17 | Code: H | nature_of_ownership: By Dean Y. Li Revocable Trust | shares_owned_after: 1,422,048.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-17 | Code: H | nature_of_ownership: By Dean Y. Li 2021 Family Trust | shares_owned_after: 421,000.00

Footnotes:

• F1: Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer.
• F2: Includes 136,981 shares of Class A common stock transferred from the Dean Y. Li GRAT on May 7, 2026.